Hydroxyurea
Composition
The formulation contains Each capsule contains Hydroxyurea 500 mg as the active ingredient.
Indications
The use of this drug is indicated in the treatment of myeloproliferative disorders and sickle cell anemia.
Side effects
Mild to moderate side effects have been observed such as nausea, vomiting, diarrhea, and myelosuppression.
Precautions
Monitor for signs of bone marrow suppression and hemorrhage.
Contraindications
Hypersensitivity to Hydroxyurea or any component, severe bone marrow suppression.
Dosage and administration
As directed by healthcare provider
Countries
We have established our roots in other countries as well, such as Nigeria, South Africa, India, and Egypt.
Available Forms
Capsules, Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai